Tracking Parkinson's: study design and baseline patient data

Journal of Parkinson's Disease

Volumn 5, Issue 4, 2015, Pages 947-959

  Malek, Naveed ^a   Swallow, Diane M A ^a   Grosset, Katherine A ^a   Lawton, Michael A ^b   Marrinan, Sarah L ^c   Lehn, Alexander C ^c   Bresner, Catherine ^d   Bajaj, Nin ^e   Barker, Roger A ^f   Ben Shlomo, Yoav ^b   Burn, David J ^c   Foltynie, Thomas ^g   Hardy, John ^h   Morris, Huw R ^g   Williams, Nigel M ^d   Wood, Nicholas ^g   Grosset, Donald G ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e QUEEN S MEDICAL CENTRE   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

genotype; heterogeneity; Parkinsons disease; phenotype

Indexed keywords

BIOLOGICAL MARKER;

AGED; ARTICLE; BRAIN RADIOGRAPHY; COMORBIDITY; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE DURATION; DRUG USE; FAMILY HISTORY; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE ASSESSMENT; RATING SCALE; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE; UNITED KINGDOM; ADULT; CLINICAL TRIAL; GENETICS; GENOTYPE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; ONSET AGE; PATHOPHYSIOLOGY; PHENOTYPE;

ADULT; AGE OF ONSET; AGED; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PHENOTYPE; RESEARCH DESIGN;

EID: 84952667395     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-150662     Document Type: Article

References (72)

1. Nussbaum RL, Ellis CE, 2003 Alzheimer's disease and Parkinson's disease. N Engl J Med 348 1356 1364
2. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM, 2007 Projected number of people with Parkinsondisease in the most populous nations, 2005 through 2030. Neurology 68 384 386
3. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M, 1997 Alpha-synuclein in Lewybodies. Nature 388 839 840
4. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL, 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 2045 2047
5. Lesage S, Brice A, 2012 Role of mendelian genes in "sporadic" Parkinson's disease. Parkinsonism Relat Disord 18 Suppl 1 S66 S70
6. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Simon-Sanchez J, Schulte C, Lesage S, Sveinbjornsdottir S, Stefansson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW, 2011 Imputation of sequence variants for identification of genetic risks for Parkinson's disease: Ameta-analysis of genome-wide association studies. Lancet 377 641 649
7. Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M, Schulte C, Keller MF, Arepalli S, Letson C, Edsall C, Stefansson H, Liu X, Pliner H, LeeJH, Cheng R, Ikram MA, Ioannidis JP, Hadjigeorgiou GM, Bis JC, Martinez M, Perlmutter JS, Goate A, Marder K, Fiske B, Sutherland M, Xiromerisiou G, Myers RH, Clark LN, Stefansson K, Hardy JA, Heutink P, Chen H, Wood NW, Houlden H, Payami H, Brice A, Scott WK, Gasser T, Bertram L, Eriksson N, Foroud T, Singleton AB, 2014 Large-scale meta-analysis of genome-wide association dataidentifies six new risk loci for Parkinson's disease. NatGenet 46 989 993
8. Simon-Sanchez J, Schulte C, Bras JM, Sharma M, Gibbs JR, Berg D, Paisan-Ruiz C, Lichtner P, Scholz SW, Hernandez DG, Kruger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M, Nalls MA, Illig T, Gieger C, Houlden H, Steffens M, Okun MS, Racette BA, Cookson MR, Foote KD, Fernandez HH, Traynor BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M, Lopez G, Chanock SJ, Schatzkin A, Park Y, Hollenbeck A, Gao J, Huang X, Wood NW, Lorenz D, Deuschl G, Chen H, Riess O, Hardy JA, Singleton AB, Gasser T, 2009 Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 41 1308 1312
9. Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, Lee JH, 2011 Genome-wide association study identifies candidategenes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet 12 104
10. Pankratz N, Nichols WC, Uniacke SK, Halter C, Murrell J, Rudolph A, Shults CW, Conneally PM, Foroud T, 2003 Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinsondisease families. Hum Mol Genet 12 2599 2608
11. Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T, 2012 Meta-analysis of Parkinson's disease: Identification of a novel locus, RIT2. Ann Neurol 71 370 384
12. Riess O, Kruger R, 1999 Parkinson's disease-a multifactorial neurodegenerative disorder. J Neural Transm Suppl 56 113 125
13. Puschmann A, 2013 Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 19 407 415
14. Declaration of Helsinki 1967 Recommendations guiding doctors in clinical research. Adopted by the World MedicalAssociation in 1964. Wis Med J 66 25 26
15. Hughes AJ, Daniel SE, Lees AJ, 2001 Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57 1497 1499
16. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE, 2010 Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25 2649 2653
17. Brennan KA, Genever RW, 2010 Managing Parkinson's disease during surgery. BMJ 341 c5718
18. Hu MT, Szewczyk-Królikowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, Talbot K, Ebmeier KP, Mackay CE, Ben-Shlomo Y, 2014 Predictors of cognitive impairment in an early stage Parkinson's disease cohort. Mov Disord 29 3 351 359
19. Ray Chaudhuri K, Rojo JM, Schapira AH, Brooks DJ, Stocchi F, Odin P, Antonini A, Brown RJ, Martinez-Martin P, 2013 Aproposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: Meeting anunmet need. PLoS One 8 e57221
20. Snaith RP, Bridge GW, Hamilton M, 1976 The Leeds scales for the self-assessment of anxiety and depression. Br J Psychiatry 128 156 165
21. Johns MW, 1991 A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14 540 545
22. Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH, 2007 The REM sleep behavior disorder screening questionnaire-a new diagnostic instrument. Mov Disord 22 2386 2393
23. Silveira-Moriyama L, Petrie A, Williams DR, Evans A, Katzenschlager R, Barbosa ER, Lees AJ, 2009 The use of a color coded probability scale to interpret smell tests in suspected parkinsonism. Mov Disord 24 1144 1153
24. WHOGlobal Database on Body Mass Index. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html. Accessed on 04/05/2015
25. Weintraub D, Papay K, Siderowf A, 2013 Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study. Neurology 80 176 180
26. Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C, 2002 The Parkinson's disease sleep scale: A new instrument forassessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 73 629 635
27. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ, 2004 Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA-AUT. Mov Disord 19 1306 1312
28. Callesen MB, Weintraub D, Damholdt MF, Moller A, 2014 Impulsive and compulsive behaviors among Danish patients with Parkinson's disease: Prevalence, depression, and personality. Parkinsonism Relat Disord 20 22 26
29. Weintraub D, David AS, Evans AH, Grant JE, Stacy M, 2015 Clinical spectrum of impulse control disorders in Parkinson's disease. Mov Disord 30 121 127
30. Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Ottman R, Marder K, Clark LN, 2010 Frequency ofknown mutations in early-onset Parkinson disease: Implication forgenetic counseling: The consortium on risk for early onset Parkinson disease study. Arch Neurol 67 1116 1122
31. Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S, Dartigues JF, Alperovitch A, Tzourio C, Rocca WA, 1999 Familial aggregationof Parkinson's disease: A population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology 52 1876 1882
32. Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, Schaid DJ, Maraganore DM, 2007 Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol 64 1458 1464
33. Costello S, Bordelon Y, Bronstein J, Ritz B, 2010 Familial associations of Alzheimer disease and essential tremor with Parkinson disease. Eur J Neurol 17 871 878
34. Schenck CH, Boeve BF, Mahowald MW, 2013 Delayed emergence of a parkinsonian disorder or dementia in 81 of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: A 16-year update on a previously reported series. Sleep Med 14 744 748
35. Mahale R, Yadav R, Pal PK, 2014 Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease: A questionnaire-based study. Sleep Med 15 642 646
36. Rolinski M, Szewczyk-Krolikowski K, Tomlinson PR, Nithi K, Talbot K, Ben-Shlomo Y, Hu MT, 2014 REM sleep behaviour disorder isassociated with worse quality of life and other non-motor featuresin early Parkinson's disease. J Neurol Neurosurg Psychiatry 85 560 566
37. Bugalho P, Viana-Baptista M, 2013 REM sleep behavior disorder and motor dysfunction in Parkinson's disease-a longitudinal study. Parkinsonism Relat Disord 19 1084 1087
38. Sixel-Doring F, Trautmann E, Mollenhauer B, Trenkwalder C, 2011 Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 77 1048 1054
39. Rana AQ, Siddiqui I, Yousuf MS, 2012 Challenges in diagnosis of young onset Parkinson's disease. J Neurol Sci 323 113 116
40. Breen DP, Evans JR, Farrell K, Brayne C, Barker RA, 2013 Determinants of delayed diagnosis in Parkinson's disease. J Neurol 260 1978 1981
41. Saunders-Pullman R, Wang C, Stanley K, Bressman SB, 2011 Diagnosis and referral delay in women with Parkinson's disease. Gend Med 8 209 217
42. Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ, Ratan RR, 2003 Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci U S A 100 4281 4286
43. Becker C, Jick SS, Meier CR, 2010 Risk of stroke in patients with idiopathic Parkinson disease. Parkinsonism Relat Disord 16 31 35
44. Lu L, Fu DL, Li HQ, Liu AJ, Li JH, Zheng GQ, 2014 Diabetes and risk of Parkinson's disease: An updated meta-analysis of case-control studies. PLoS One 9 e85781
45. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J, 2007 Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30 842 847
46. Kotagal V, Albin RL, Muller ML, Koeppe RA, Frey KA, Bohnen NI, 2014 Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology 82 1514 1520
47. Jones JD, Jacobson C, Murphy M, Price C, Okun MS, Bowers D, 2014 Influence of hypertension on neurocognitive domains in nondemented Parkinson's disease patients. Parkinsons Dis 2014 507529
48. Wang T (2014) The link between Parkinson's disease and breast and prostate cancers: A meta-analysis. Int J Neurosci, 2014 Dec 18. [Epub ahead of print]
49. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, 2011 Global cancer statistics. CA Cancer J Clin 61 69 90
50. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I, 1990 Variable expression of Parkinson's disease: A base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40 1529 1534
51. Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA, 2013 The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84 1258 1264
52. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D, 2006 Changes in motor subtype and risk for incident dementiain Parkinson's disease. Mov Disord 21 1123 1130
53. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, McKeith IG, 2006 Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77 585 589
54. Baumann CR, Held U, Valko PO, Wienecke M, Waldvogel D, 2014 Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression. Mov Disord 29 207 213
55. Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ, 2014 Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord 29 195 202
56. Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M, 2012 Diagnostic criteria for mild cognitive impairmentin Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27 349 356
57. Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ, 2014 Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD study. Neurology 82 308 316
58. de la Riva P, Smith K, Xie SX, Weintraub D, 2014 Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology 83 1096 1103
59. Suzuki K, Miyamoto T, Miyamoto M, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K, 2008 Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease. J Neurol Sci 271 47 52
60. Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT, 2013 Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease. Parkinsonism Relat Disord 19 806 811
61. Mahale R, Yadav R, Pal PK, 2015 Quality of sleep in young onset Parkinson's disease: Any difference fromolder onset Parkinson's disease. Parkinsonism Relat Disord 21 461 464
62. Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B, 2012 Sleep problems in Parkinson's disease: A community-based study inNorway. BMC Neurol 12 71
63. Pellecchia MT, Antonini A, Bonuccelli U, Fabbrini G, Ferini Strambi L, Stocchi F, Battaglia A, Barone P, 2012 Observational study of sleep-related disorders in Italian patients with Parkinson's disease: Usefulness of the Italian version of Parkinson's disease sleep scale. Neurol Sci 33 689 694
64. Rijsman RM, Schoolderman LF, Rundervoort RS, Louter M, 2014 Restless legs syndrome in Parkinson's disease. Parkinsonism Relat Disord 20 Suppl 1 S5 S9
65. Mollenhauer B, Trautmann E, Sixel-Doring F, Wicke T, Ebentheuer J, Schaumburg M, Lang E, Focke NK, Kumar KR, Lohmann K, Klein C, Schlossmacher MG, Kohnen R, Friede T, Trenkwalder C, 2013 Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology 81 1226 1234
66. Kurtis MM, Rodriguez-Blazquez C, Martinez-Martin P, 2013 Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 19 1152 1155
67. Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, de Pedro-Cuesta J, Martinez-Martin P, 2010 Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT). Eur J Neurol 17 194 201
68. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ, 2007 Patient-reported autonomic symptoms inParkinson disease. Neurology 69 333 341
69. Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB, 2014 Predictors of dementia in Parkinson disease: A prospective cohort study. Neurology 83 1253 1260
70. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A, 2012 Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72 893 901
71. Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K, 2012 Impairedolfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 27 406 412
72. Krogh K, Ostergaard K, Sabroe S, Laurberg S, 2008 Clinical aspects of bowel symptoms in Parkinson's disease. Acta Neurol Scand 117 60 64